Editor’s Choice: What’s Happening in Treatment News?

Happy Friday everyone!

This was a week with a highlight on research: we cover the state of ME/CFS information at the moment, an exciting treatment approval for people with ulcerative colitis, and a positive study for the glioblastoma. Additionally, we have a story shared by a family who lost a daughter to mitochondrial disease.

Sit back and enjoy this week’s Editor’s Choice.

 

The State of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Research in 2018

We watched a great lecture on the current state of ME/CFS research– we recommend you watch the whole thing on youtube, but if you don’t have have time, check out our highlights here.

 

“She Led the Life of a Carefree Child With No Limitations” Connor Family Faces Heartbreak After Losing Child to Mitochondrial Disease

Many rare families have to face the devastation of losing a child. The Connor family speaks about the journey they faced after the passing of their daughter.

Read about it here.

 

DCVax: A Promising New Treatment for Glioblastoma

Glioblastoma is a devastating form of brain cancer– however researchers are working on using the immune system to combat it.

Read about it here.

 

Ulcerative Colitis Patients Have a New FDA Approved Treatment

For those suffering from ulcerative colitis, the FDA has good news for you! A treatment may be headed your way!

Read about it here.


Do you have a rare disease experience of your own? Share with us here.

Share this post

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

© Copyright Patient Worthy

Close Menu